Taisheng Li to SARS Virus
This is a "connection" page, showing publications Taisheng Li has written about SARS Virus.
Connection Strength
0.315
-
Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients. Scand J Infect Dis. 2011 Jul; 43(6-7):515-21.
Score: 0.083
-
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec; 9(1):727-732.
Score: 0.041
-
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Sci Adv. 2020 11; 6(45).
Score: 0.041
-
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates. ACS Infect Dis. 2016 05 13; 2(5):361-76.
Score: 0.030
-
Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients. Virol J. 2010 Nov 04; 7:299.
Score: 0.020
-
The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80.
Score: 0.020
-
Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J Virol. 2010 Nov; 84(22):11849-57.
Score: 0.020
-
Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol. 2007 May; 81(9):4694-700.
Score: 0.016
-
Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One. 2006 Dec 20; 1:e24.
Score: 0.015
-
Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol. 2004 Oct; 78(20):11334-9.
Score: 0.013
-
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis. 2004 Sep 15; 190(6):1119-26.
Score: 0.013
-
[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia]. Presse Med. 2004 Mar 13; 33(5):344-51.
Score: 0.003